BIOMARIN PHARMACEUTICAL INC (NASDAQ: BMRN)

NASDAQ: BMRN (BioMarin Pharmaceutical Inc.)

Kemas kini terakhir: 12 Oct, 4:59AM

-0.09 (-0.17%)

Tambah ke senarai pantauan

Penutupan Terdahulu	54.89
Jumlah Dagangan	2,146,377

Harga / Pendapatan (P/E Ke hadapan)	9.40
Harga / Jualan (P/S)	3.58
Harga / Buku (P/B)	1.90

Julat 52 Minggu

49.26 (-10%) — 70.98 (29%)

Arah Aliran Pasaran

		Jangka Pendek	Jangka Sederhana
Industri	Biotechnology (US)	Bercampur	Menaik
	Biotechnology (Global)	Bercampur	Menaik
Stok	BioMarin Pharmaceutical Inc.	Bercampur	Menurun

AISkor Stockmoo

-0.6

Saham Serupa

Stok	Modal Pasaran	DY	P/E (TTM)	P/B
BMRN	-	-	-	1.90
TLX	3 B	-	94.85	7.85
VRTX	136 B	-	30.99	6.46
MESO	2 B	-	-	3.50
BBIO	13 B	-	-	-
CYTK	9 B	-	-	-

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
Sektor	Healthcare
Industri	Biotechnology
Gaya Pelaburan	Mid Growth
% Dimiliki oleh Orang Dalam	0.77%
% Dimiliki oleh Institusi	98.91%

Tiada data dalam julat masa ini.

AI Analisis Teknikal

Buka tab Teknikal untuk menjana analisis terkini.

Portfolio

AI Templat

Peringatan harga anda

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Tiada saham yang memenuhi kriteria anda

Margin Keuntungan	17.76%
Margin Operasi (TTM)	30.05%
EPS Cair (TTM)	2.70
Pertumbuhan Hasil Suku Tahunan (YOY)	14.80%
Pertumbuhan Pendapatan Suku Tahunan (YOY)	109.40%

Jumlah Hutang/Ekuiti (D/E MRQ)	10.39%
Nisbah Semasa (MRQ)	5.52
Aliran Tunai Operasi (OCF TTM)	700.26 M
Aliran Tunai Bebas Leveraj (LFCF TTM)	411.56 M

Pulangan Atas Aset (ROA TTM)	6.38%
Pulangan Atas Ekuiti (ROE TTM)	9.64%